84 related articles for article (PubMed ID: 21054517)
1. Sophocarpine alleviates non-alcoholic steatohepatitis in rats.
Song CY; Zeng X; Chen SW; Hu PF; Zheng ZW; Ning BF; Shi J; Xie WF; Chen YX
J Gastroenterol Hepatol; 2011 Apr; 26(4):765-74. PubMed ID: 21054517
[TBL] [Abstract][Full Text] [Related]
2. Preventive role of genistein in an experimental non-alcoholic steatohepatitis model.
Yalniz M; Bahcecioglu IH; Kuzu N; Poyrazoglu OK; Bulmus O; Celebi S; Ustundag B; Ozercan IH; Sahin K
J Gastroenterol Hepatol; 2007 Nov; 22(11):2009-14. PubMed ID: 17914984
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic effects of cytokine modulator Y-40138 in the rat alcoholic liver disease model.
Kawaratani H; Tsujimoto T; Kitazawa T; Yoshiji H; Uemura M; Fukui H
J Gastroenterol Hepatol; 2011 Apr; 26(4):775-83. PubMed ID: 21251062
[TBL] [Abstract][Full Text] [Related]
4. Sophocarpine alleviates hepatocyte steatosis through activating AMPK signaling pathway.
Song CY; Shi J; Zeng X; Zhang Y; Xie WF; Chen YX
Toxicol In Vitro; 2013 Apr; 27(3):1065-71. PubMed ID: 23395669
[TBL] [Abstract][Full Text] [Related]
5. The role of cytokines in non-alcoholic steatohepatitis. A review.
Copaci I; Micu L; Voiculescu M
J Gastrointestin Liver Dis; 2006 Dec; 15(4):363-73. PubMed ID: 17205149
[TBL] [Abstract][Full Text] [Related]
6. Marked elevation of serum mitochondrion-derived markers in mild models of non-alcoholic steatohepatitis in rats.
Murayama H; Ikemoto M; Nagata A
J Gastroenterol Hepatol; 2009 Feb; 24(2):270-7. PubMed ID: 18823438
[TBL] [Abstract][Full Text] [Related]
7. Hepatic lipid metabolism and non-alcoholic fatty liver disease.
Tessari P; Coracina A; Cosma A; Tiengo A
Nutr Metab Cardiovasc Dis; 2009 May; 19(4):291-302. PubMed ID: 19359149
[TBL] [Abstract][Full Text] [Related]
8. Evidence-based efficacy of Kampo formulas in a model of non alcoholic fatty liver.
Fujimoto M; Tsuneyama K; Kainuma M; Sekiya N; Goto H; Takano Y; Terasawa K; Selmi C; Gershwin ME; Shimada Y
Exp Biol Med (Maywood); 2008 Mar; 233(3):328-37. PubMed ID: 18296738
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of JNK along with activation of ERK1/2 MAPK pathways improve steatohepatitis among the rats.
Aghazadeh S; Yazdanparast R
Clin Nutr; 2010 Jun; 29(3):381-5. PubMed ID: 19748164
[TBL] [Abstract][Full Text] [Related]
10. Effect of atorvastatin and diet on non-alcoholic fatty liver disease activity score in hyperlipidemic chickens.
Martín-Castillo A; Castells MT; Adánez G; Polo MT; Pérez BG; Ayala I
Biomed Pharmacother; 2010 Apr; 64(4):275-81. PubMed ID: 19932590
[TBL] [Abstract][Full Text] [Related]
11. Hepatoprotective effects of geniposide in a rat model of nonalcoholic steatohepatitis.
Ma T; Huang C; Zong G; Zha D; Meng X; Li J; Tang W
J Pharm Pharmacol; 2011 Apr; 63(4):587-93. PubMed ID: 21401612
[TBL] [Abstract][Full Text] [Related]
12. Non-alcoholic steatohepatitis in children.
Nanda K
Pediatr Transplant; 2004 Dec; 8(6):613-8. PubMed ID: 15598336
[TBL] [Abstract][Full Text] [Related]
13. Intrahepatic cholesterol influences progression, inhibition and reversal of non-alcoholic steatohepatitis in hyperlipidemic mice.
Wouters K; van Bilsen M; van Gorp PJ; Bieghs V; Lütjohann D; Kerksiek A; Staels B; Hofker MH; Shiri-Sverdlov R
FEBS Lett; 2010 Mar; 584(5):1001-5. PubMed ID: 20114046
[TBL] [Abstract][Full Text] [Related]
14. Anti-nociceptive and anti-inflammatory activity of sophocarpine.
Gao Y; Li G; Li C; Zhu X; Li M; Fu C; Li B
J Ethnopharmacol; 2009 Sep; 125(2):324-9. PubMed ID: 19607897
[TBL] [Abstract][Full Text] [Related]
15. Hepatic histology in obese patients undergoing bariatric surgery.
Machado M; Marques-Vidal P; Cortez-Pinto H
J Hepatol; 2006 Oct; 45(4):600-6. PubMed ID: 16899321
[TBL] [Abstract][Full Text] [Related]
16. Animal models of NASH: getting both pathology and metabolic context right.
Larter CZ; Yeh MM
J Gastroenterol Hepatol; 2008 Nov; 23(11):1635-48. PubMed ID: 18752564
[TBL] [Abstract][Full Text] [Related]
17. Amelioration of non-alcoholic steatohepatitis and glucose intolerance in ob/ob mice by oral immune regulation towards liver-extracted proteins is associated with elevated intrahepatic NKT lymphocytes and serum IL-10 levels.
Elinav E; Pappo O; Sklair-Levy M; Margalit M; Shibolet O; Gomori M; Alper R; Thalenfeld B; Engelhardt D; Rabbani E; Ilan Y
J Pathol; 2006 Jan; 208(1):74-81. PubMed ID: 16261527
[TBL] [Abstract][Full Text] [Related]
18. Association of liver disease with postprandial large intestinal triglyceride-rich lipoprotein accumulation and pro/antioxidant imbalance in normolipidemic non-alcoholic steatohepatitis.
Musso G; Gambino R; De Michieli F; Biroli G; Fagà E; Pagano G; Cassader M
Ann Med; 2008; 40(5):383-94. PubMed ID: 18484349
[TBL] [Abstract][Full Text] [Related]
19. [Therapeutic effects of compound glycyrrhizin liposome on fibrosis of the rats with nonalcoholic steatohepatitis].
Ye HJ; Wei SL; Wang HC; Liu XY; Wan HJ; Yi XR; Yuan YC; Kong XP
Zhonghua Gan Zang Bing Za Zhi; 2009 Nov; 17(11):877-8. PubMed ID: 19958654
[No Abstract] [Full Text] [Related]
20. Lack of therapeutic effects of gabexate mesilate on the hepatic encephalopathy in rats with acute and chronic hepatic failure.
Hsu CY; Lee FY; Huo TI; Chan CY; Huang HC; Lin HC; Chang CC; Teng TH; Wang SS; Lee SD
J Gastroenterol Hepatol; 2010 Jul; 25(7):1321-8. PubMed ID: 20594263
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
